This announcement is a separate document:
深圳价值在线咨询顾问有限公司关于杭州奥泰生物技术股份有限公司2022年限制性股票激励计划预留授予第一个归属期符合归属条件事项之独立财务顾问报告
Shenzhen Valuation Online Consulting Limited's independent financial advisor report on Hangzhou Otech Biotechnology Co., Ltd.'s 2022 restricted stock incentive plan for the first vesting period reserved for the fulfillment of attribution conditions.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated